THOMAS COMSTOCK: Open Payments
NPI 1497782346 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 25 payments from 11 companies in 2025. Trend: 2023 $667 · 2024 $412 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $98 |
| PFIZER INC. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: JARDIANCE, MOUNJARO, TRINTELLIX, NURTEC ODT, PAXLOVID, VRAYLAR, ELIQUIS, ENTRESTO.
Industry payments across IN — which companies pay providers there.
